用dronabinol治疗的大麻素相关的超导综合征:用毒药杀死一种毒药
Azhar Hussain1, Sistu Kc2, Fnu Sapna1
1Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
Cureus
|January 1, 2024
概括
大麻素高症候群 (CHS) 是一种导致经常使用大麻的人严重恶心和吐的疾病. 这份病例报告显示,德罗纳醇有效地消除了CHS症状,突出了其作为治疗选择的潜力.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 大麻素高症候群 (CHS) 是一种与慢性,大量使用大麻相关的疾病,呈现为周期性恶心,吐和腹痛.
- 随着CHS的流行日益增加,特别是大麻合法化日益广泛,医疗保健提供者需要有效的管理策略.
- 目前对CHS的治疗方案往往具有症状,可能无法有效地解决潜在的病理生理学问题.
研究的目的:
- 报告一例使用dronabinol成功治疗大麻素激增症候群 (CHS) 的病例.
- 强调全面的病史在诊断复杂的胃肠道疾病的重要性.
- 提高医疗保健提供者对CHS及其管理的认识.
主要方法:
- 一份病例报告详细介绍了一名21岁的女性患者,其严重症状与CHS一致.
- 最初使用症状疗法和哈洛佩里多尔进行治疗,结果证明无效或恶化.
- 用于症状管理和解决的德罗纳比诺尔的管理.
主要成果:
- 一次剂量德罗纳宾醇导致患者的恶心,吐和腹痛显著改善.
- 随后的多纳醇剂量导致了大麻素过度复杂综合征症状的完全消失.
- 哈洛佩里多尔的使用与兴奋和症状恶化有关.
结论:
- 德罗纳醇在治疗大麻素过度复杂综合征方面表现出潜在的有效性.
- 完整的病史和认出CHS对于适当的诊断和治疗至关重要.
- 需要进一步的研究,以建立基于证据的指导方针,用于CHS管理中使用dronabinol.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
279
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
279
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
165
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
165
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
295
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
295
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
206
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
206
01:17Drugs for Treatment of Diarrhea-Predominant IBS
177
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
177
01:21Drugs for Treatment of Constipation-Predominant IBS
172
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
172